Britain announced this week that it would lift restrictions. experiment It may have had a negative impact on the child's bone density, cognitive performance, emotional stability, and future fertility.
England's National Health Service announced in March that it would no longer prescribe puberty blockers to minors in so-called gender identity clinics, saying: “We do not believe there is sufficient evidence to support their safety or clinical effectiveness.'' I have come to a conclusion.” [puberty-suppressing hormones] This is to ensure that you receive regular treatment at this time. ”
A few months later, Victoria Atkin, then UK Secretary of State for Health and Social Care, used emergency powers to ensure that “puberty blockers, a new treatment for gender dysphoria, were brought to the UK from private clinics and from overseas prescribers.'' decided to prohibit its use for any purpose. The ban on private sales will come into effect from January 1, 2025.
On Wednesday, the UK Department of Health and Social Care said:
announced England, Northern Ireland, Scotland and Wales have announced that existing emergency measures banning the sale and supply of puberty blockers will be “extended indefinitely following official advice from medical experts”.
“The Committee for Human Medicines (CHM) has provided independent expert advice that the continued prescribing of puberty blockers in children currently poses an unacceptable safety risk. “We are recommending indefinite restrictions while work is carried out to ensure the safety of young people,” the ministry said in a release.
“Puberty blockers are powerful drugs that have no proven efficacy but come with significant risks.”
Blaze News previously reported that the drug in question, a luteinizing hormone-releasing hormone agonist (also known as GnRHa), has been used for a long time Chemically castrating sex offenders.
According to Between 2019 and 2023, at least 13,994 American minors underwent gender reassignment treatment, and more than 8,500 were treated with hormones or drugs, according to the medical advocacy group Do No Harm's Stop the Harm database. Receiving puberty blockers. free press noticed In August, it was announced that Planned Parenthood is the primary provider of sex-change hormones to young people in the United States.
Puberty blockers have been rebranded for gender-confused children and have been characterized as safe and effective by LGBT activists and pharmaceutical officials. However, this story did not survive.
Cath Review Release Earlier this year, at least on the other side of the Atlantic.
Dr Hilary Cass, a renowned British doctor and former president of the Royal College of Paediatrics and Child Health, was asked by NHS England to investigate the UK's gender reassignment system and its services for young people. . The exhaustive review found that when it comes to so-called gender science, “there is no reliable evidence to inform clinical decisions or to help children and their families make informed choices.”
It noted that so-called gender science is largely based on “poor quality” research, exhibiting “poor study designs, inadequate follow-up periods, and a lack of objectivity in reporting results,” as well as the Cass Review. denied this matter. He stressed that the use of puberty blockers is “unproven and the benefits and harms are unknown.”
The review found that puberty blockers not only impair bone density but also have no apparent effect on so-called gender dysphoria.
Commenting on the indefinite ban, Dr Cass said: “We support the Government's decision to continue with restrictions on the dispensing of puberty blockers for gender dysphoria outside of the NHS, where these important safeguards are not provided.”
“Puberty blockers are powerful drugs that, while unproven, carry significant risks. That is why I recommend that they should be prescribed only within research protocols after a multidisciplinary evaluation. That's why we did it,” Dr. Cass added.
“Children's medical care must always be evidence-based.”
James Palmer, NHS medical director for specialist services, said: “The evidence review by NICE and NHS England, supported by Dr Cass, found that there was insufficient evidence to support the safety and clinical effectiveness of puberty suppressing hormones in the treatment of gender differences. It has been clearly shown that there is no evidence of this.” The NHS has decided not to routinely offer it to children and young people because of discomfort and discomfort. ”
The UK health system now focuses on providing holistic support and working with patients on their mental health, rather than putting deranged children on transformation drugs or removing body parts. is placed.
Wes Streeting, the current Health and Social Care Secretary, said: 'Children's healthcare must always be evidence-based. “We found that the prescription and care pathway posed an unacceptable safety risk to children.” And young people. ”
“Dr. Kass' review also raised safety concerns about the lack of evidence for these treatments,” Streeting continued. “We must all act with caution and caution with these vulnerable young people and follow expert advice.”
While the UK has become wiser to the potential risks of adolescent disincentives, the US side, a well-funded and ideologically driven regime, has not suffered a similar national blow.
In a New York Times interview in May, Dr. Kass criticized certain American Medical Associations, suggesting that, for example, the American Academy of Pediatrics has repeatedly criticized them. uttered abusive language Opposing Republican-led states to protect children from child sex reassignment mutilation, they “adhere to positions that have now been proven outdated by multiple systematic reviews.”
“It wouldn't really matter if people said, 'This is the clinical consensus and we're not sure,'” Kass suggested. But what some organizations are doing is claiming that the evidence is good, and I think that's where they're misleading the public. ”
Of the 28 states where Republicans control their legislatures, 24 red states have successfully passed bans to protect children from puberty blockers, hormone therapy, and sex-reassignment mutilation.
reported New York Times. Federal judge Robert Hinkle, a Clinton appointee, suggested that those Republicans were actually acting on an “outdated, discriminatory animus.”
The U.S. Supreme Court last week heard arguments regarding Tennessee's ban on puberty blockers. Should the High Court uphold the ban in ruling?
USA vs. Scumetti Similar bans will be tightened across the country sometime next year.
Do you like Blaze News? Avoid censorship and sign up for our newsletter to get articles like this delivered straight to your inbox. Please register here!
